MIRAGRON S 25/5:Uses, Benefits, Dosage, Price & Side Effects ..

MIRAGRON S 25/5

Mirabegron (ER) (25mg) and Solifenacin succinate (5mg)

MIRAGRON S 25/5 combination of Mirabegron (ER) (25mg) and Solifenacin Succinate (5mg), collectively known as MIRAGRON S 25/5, represent a combination medication used for the management of overactive bladder (OAB) symptoms. This article aims to explore their uses, dosage guidelines, potential side effects, and other essential information.

Understanding Mirabegron (ER) (25mg) and Solifenacin Succinate (5mg):

• MIRAGRON S 25/5 combines the pharmacological actions of mirabegron, a beta-3 adrenergic agonist, and solifenacin succinate, a muscarinic receptor antagonist, to effectively alleviate symptoms of OAB.
• Mirabegron works by relaxing the detrusor muscle in the bladder, while solifenacin inhibits the effects of acetylcholine, leading to decreased bladder contractions and increased bladder capacity.

Uses of Mirabegron (ER) (25mg) and Solifenacin Succinate (5mg):

• Symptom Relief: MIRAGRON S 25/5 is indicated for the treatment of urinary urgency, frequency, and urge incontinence associated with OAB.
• Improved Bladder Control: By targeting both muscle and nerve activity in the bladder, this combination therapy helps restore normal bladder function and reduce OAB symptoms.

Dosage Guidelines:

• The recommended dosage of MIRAGRON S 25/5 typically involves one tablet taken orally once daily, preferably with water, with or without food.
• Dosage adjustments may be necessary based on individual patient response and tolerability, as assessed by the prescribing healthcare provider.

Potential Side Effects:

• Anticholinergic Effects: Common side effects associated with solifenacin succinate may include dry mouth, constipation, blurred vision, and urinary retention.
• Cardiovascular Effects: Mirabegron may lead to increases in blood pressure and heart rate, particularly in patients with pre-existing cardiovascular conditions.
• Central Nervous System Effects: While rare, individuals may experience dizziness, headache, or confusion while undergoing treatment with MIRAGRON S 25/5.

Precautions and Considerations:

• Patient Education: Educating patients about potential side effects and advising them to report any adverse reactions promptly facilitates active participation in their treatment journey.
• Regular Monitoring: Periodic assessment of blood pressure, heart rate, and bladder symptoms enables early detection and management of potential adverse effects.
• Tailored Therapy: Customizing treatment plans based on individual patient characteristics optimizes therapeutic outcomes while minimizing risks.

Conclusion:

Mirabegron (ER) (25mg) and Solifenacin Succinate (5mg), or MIRAGRON S 25/5, offer a comprehensive approach to alleviating OAB symptoms by targeting both muscle and nerve activity in the bladder. By adhering to prescribed dosage guidelines, monitoring for potential side effects, and embracing precautionary measures, healthcare providers can effectively manage OAB symptoms and improve patient quality of life.A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology. 

For further information: EMAIL:  info@sterispharma.com  / contact@sterispharma.com    

CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 

BUY NOW